No difference in dementia prediction between apolipoprotein E4 and the ischemic score.

Area of Science:

• Neurology
• Geriatrics
• Biomarker Research

Background:

• Vascular cognitive impairment lacks sufficient early detection biomarkers.
• Identifying reliable predictors for dementia is crucial for timely intervention.

Purpose of the Study:

• To evaluate the Hachinski Ischemic Scale (HIS) as a predictor of dementia in the elderly.
• To compare the predictive performance of HIS against apolipoprotein E (APOE ɛ4).

Main Methods:

• Utilized data from the Canadian Study of Health and Aging.
• Examined the association between HIS scores and incident dementia.
• Developed and validated predictive models for dementia using HIS and APOE ɛ4 in training and validation datasets.

Main Results:

• Higher HIS scores significantly correlated with increased odds of dementia (OR = 1.64).
• The dementia prediction accuracy of the HIS model was comparable to the APOE ɛ4 model (AUC difference = 0.002).
• Both HIS and APOE ɛ4 models demonstrated acceptable calibration.

Conclusions:

• The Hachinski Ischemic Scale serves as a valuable, accessible tool for identifying elderly individuals at risk of dementia.
• HIS offers a practical alternative for dementia risk assessment in clinical settings.